Raleigh ag biotech startup led by Black cofounder & CEO pivots to fight pandemic
Date Published:
RESEARCH TRIANGLE PARK – In the early days of the COVID-19 pandemic, there were shortages of many critical resources, from…
Life Sciences
Brain breakthrough? Duke scientists help create first living, bioprinted aneurysm outside of human body
Date Published:
DURHAM – Brain aneurysms affect about one in every 50 Americans and can lead to serious medical emergencies, including stroke,…
Durham startup Tellus moves closer to OK for neonatal brain treatment
Date Published:
DURHAM – Tellus Therapeutics is getting closer to approval for its neonatal brain injury treatment.
This week, the Durham-based biotech…
Now hear this: Durham’s MED-EL Medical Electronics wins Innovator award
Date Published:
RESEARCH TRIANGLE PARK – MED-EL Medical Electronics, a hearing-technology company with U.S. headquarters in Durham, was recently named “Innovator of…
Gene editing shows promise as tool to fight neuro disorder in babies, UNC study finds
Date Published:
CHAPEL HILL – Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe…
‘A major pest:’ NCSU researcher helps unravel genetic blueprint of a bug ‘that’s on everything’
Date Published:
RALEIGH – The western flower thrips — an invasive insect that’s not much bigger than a pinhead — takes a…
IQVIA’s CEO: Life science giant ‘delivering results above our financial targets’
Date Published:
DURHAM – IQVIA Holdings Inc. (IQV) on Tuesday reported third-quarter profit of $101 million.
The Durham, North Carolina-based company said…
Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M
Date Published:
Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…
Merck’s expansion in Durham reflects huge legacy of Maurice Hilleman
Date Published:
DURHAM — As you walk through the imposing glass front entrance at Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing…